LUCENTIS® (ranibizumab injection) is a prescription medicine for the treatment of patients with wet age-related macular degeneration (AMD).
LUCENTIS is a breakthrough treatment for wet AMD that can do more than just help you maintain your vision. With LUCENTIS, people with wet AMD may see their vision improve or keep the vision they have.
LUCENTIS is an FDA-approved treatment specifically developed for the treatment of wet AMD.
Of patients in key clinical studies taking LUCENTIS monthly:
- Up to 40% of patients had a significant improvement of at least 3 more lines (15 letters) on the eye chart.
- 70% of patients could see at least 1 more letter on the eye chart.
- 95% of patients had their eyesight stay the same (lost fewer than 15 letters or 3 lines).
- Up to 40% of patients achieved vision of 20/40 or better.
Lucentis Videos:
Physicians providing Lucentis consultations:
|
